Task-evoked eye movements as candidate digital biomarkers of depression severity in adolescents and young adults
Artificial Intelligence
Summary
The gist is being written…
Authors
Youxiang Sun, Yujie Nie, Zhuoru Wu, Mengyuan Yu, Wenkong Wang, Xiang Li, Yumei Wang, Xin Ma, Lizhou Fan
Abstract
Objective digital measures of depression severity could complement conventional symptom assessments and facilitate more timely clinical evaluation. Here, we investigated whether task-evoked eye movements provide interpretable behavioral markers of depression severity in adolescents and young adults. In this single-center, cross-sectional study, 155 participants aged 14--20 years completed emotional-spatial free-viewing and memory-guided recall tasks and were stratified by 17-item Hamilton Depression Rating Scale scores. We examined 19 prespecified eye-movement features across six task-informed domains using covariate-adjusted ordinal-trend models. Greater depression severity was associated with lower gaze-allocation entropy (standardized $β=-0.599$), fewer inter-area switches ($β=-0.526$), longer first target-entry latency ($β=0.572$), and lower target dwell proportion ($β=-0.678$; all false-discovery-rate-adjusted $q<0.001$). Emotion-specific attentional-bias measures were not associated with severity, whereas associations involving fixation dispersion weakened after adjustment for anxiety symptoms. In a complementary machine-learning analysis incorporating 44 candidate eye-movement features and demographic covariates, a three-stage cascade classifier achieved the highest four-class stratification performance (accuracy, 0.665; macro-F1, 0.670; area under the receiver operating characteristic curve, 0.869), outperforming single-stage and two-stage approaches. Together, these findings identify altered visual exploration and memory-guided gaze control as candidate digital biomarkers of depression severity, rather than generalized negative attentional bias. These results support further prospective evaluation of task-evoked eye tracking as a complementary approach for timely severity assessment and clinical decision support.